Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study

Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study

Background/Aims Sofosbuvir plus ribavirin is a standard treatment for patients infected with chronic hepatitis C virus (HCV) genotype 2 in Korea. The purpose of this study was to examine the efficacy and safety of this treatment in Korean patients with chronic HCV genotype 2 infection. Methods We re...

Full description

Bibliographic Details
Main Authors: Young Min Kim, Suk Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Myeong Jun Song, Ji Woong Jang, Soon Young Ko, Jae Dong Lee
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2018-09-01
Series:Clinical and Molecular Hepatology
Subjects:
Sofosbuvir
Ribavirin
Hepatitis C virus
Korea
Online Access:http://e-cmh.org/upload/pdf/cmh-2017-0070.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2017-0070.pdf

Similar Items